Source: EURLEX
Language: en
Format: md

Judgment of the General Court (Sixth Chamber) of 12 January 2022 –  
Laboratorios Ern v EUIPO – Malpricht (APIRETAL)

(Case T‑160/21)

(EU trade mark – Revocation proceedings – Word mark APIRETAL – Declaration of revocation – No genuine use – No proper reasons for non-use – Article 58(1)(a) of Regulation (EU) 2017/1001)

| 1. | EU trade mark – Surrender, revocation and invalidity – Causes of revocation – Absence of genuine use of a trade mark – Proof of use – Genuine use – Concept – Criteria for assessment – Medicinal products  (European Parliament and Council Regulation 2017/1001, Arts 18(1) and 58(1)(a))  (see paras 16-21) |

| 2. | EU trade mark – Surrender, revocation and invalidity – Causes of revocation – Absence of genuine use of a trade mark – Word mark APIRETAL  (European Parliament and Council Regulation 2017/1001, Arts 18(1) and 58(1)(a))  (see paras 26, 34, 35) |

| 3. | EU trade mark – Surrender, revocation and invalidity – Causes of revocation – Absence of genuine use of a trade mark – Concept of ‘proper reasons’ for non-use – Independent and uniform interpretation – Obstacles bearing a direct relation to the trade mark rendering its use unreasonable or impossible and independent of the volition of the trade mark proprietor  (European Parliament and Council Regulation 2017/1001, Arts 18(1) and 58(1)(a))  (see paras 30-32) |

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 20 January 2021 (Case R 1004/2020‑4), relating to revocation proceedings between Ms Malpricht and Laboratorios Ern.

Operative part

The Court:

| 1. | Dismisses the action; |

| 2. | Orders Laboratorios Ern, SA to pay the costs. |

[Top](#document1)